Evidence map›Paper›PMID 19448536›Full record

ReviewCurrent opinion in nephrology and hypertension2009

Do osteocytes contribute to phosphate homeostasis?

Jian Q Feng, Ling Ye, Susan Schiavi

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in nephrology and hypertension, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Phosphate Metabolism in Health and Disease.Calcified tissue international · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Autophagy as a target for glucocorticoid-induced osteoporosis therapy.Cellular and molecular life sciences : CMLS · 2018
    Review
  15. Alpha Klotho and phosphate homeostasis.Journal of endocrinological investigation · 2014
    Review
  16. Glucocorticoid dose determines osteocyte cell fate.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Article
  17. Article
  18. FGF23 and the parathyroid glands.Pediatric nephrology (Berlin, Germany) · 2010
    Review
  19. DMP1 C-terminal mutant mice recapture the human ARHR tooth phenotype.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jian Q FengDepartment of Biomedical Sciences, Texas A&M Health Science Center, Baylor College of Dentistry, Dallas, Texas 75246, USA. jfeng@bcd.tamhsc.edu
Ling Ye
Susan Schiavi
GTx (United States) · USUniversity of Missouri–Kansas City · US

Funding

Transgenic CoreP01AR046798 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI BONEWALD, LYNDA F · 2001 to 2010
$10.5M
A Critical Role of DMP-1 in MineralizationR01AR051587 · NIAMS · UNIVERSITY OF MISSOURI KANSAS CITY · PI FENG, JIAN Q. · 2004 to 2007
$1.1M
NIAMS NIH HHS AR046798NIAMS NIH HHS AR051587NIAMS NIH HHS P01 AR046798NIAMS NIH HHS R01 AR051587
6 · The paper itself

Abstract

Osteocytes, the terminally differentiated cell of the osteoblast lineage, account for over 90% of all bone cells. Due to their relative inaccessibility within mineralized matrix, little is known regarding their specific functions in comparison to the well studied surface bone cells, osteoblasts and osteoclasts. Furthermore, bone is often viewed as a mineral reservoir that passively releases calcium and phosphate in response to hormones secreted from remote organs. Noncollagenous matrix proteins produced in osteocytes, such as dentin matrix protein 1 (DMP1), have also been viewed as inert scaffolds for calcium-phosphate deposition. Recent discoveries of new genetic mutations in human diseases and development of genetically engineered animal models challenge these classic paradigms, suggesting that the osteocyte plays an active role in both mineralization and total systemic phosphate regulation. In this review, we will focus on roles of osteocytes in mineralization and particularly in phosphate regulation via the DMP1- FGF23 pathway.

Indexed as

HomeostasisAnimalsCalcification, PhysiologicCell LineageChronic DiseaseExtracellular Matrix ProteinsFibroblast Growth Factor-23Fibroblast Growth FactorsGlycoproteinsHumansKidney DiseasesOsteocytesPHEX Phosphate Regulating Neutral EndopeptidasePhosphatesPhosphoproteinsDMP1 protein, humanExtracellular Matrix ProteinsFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth FactorsGlycoproteinsMEPE protein, humanPHEX Phosphate Regulating Neutral EndopeptidasePHEX protein, humanPhosphatesPhosphoproteins

Identifiers

PMID19448536
PMCPMC4005871
OpenAlexW1982817150

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.